Yeo TK, Nagy JA, Yeo KT, Dvorak HF, Toole BP: Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells. Am J Pathol. 1996, 148: 1733-40.
CAS
PubMed
PubMed Central
Google Scholar
Yamada Y, Itano N, Narimatsu H, Kudo T, Hirohashi S, Ochiai A, Niimi A, Ueda M, Kimata K: Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res. 1999, 90: 987-92.
Article
CAS
PubMed
Google Scholar
Assmann V, Marshall JF, Fieber C, Hofmann M, Hart IR: The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J Cell Sci. 1998, 111: 1685-94.
CAS
PubMed
Google Scholar
Turley EA, Moore D, Hayden LJ: Characterization of hyaluronate binding proteins isolated from 3T3 and murine sarcoma virus transformed 3T3 cells. Biochemistry. 1987, 26: 2997-3005. 10.1021/bi00385a007.
Article
CAS
PubMed
Google Scholar
Yamano Y, Uzawa K, Shinozuka K, Fushimi K, Ishigami T, Nomura H, Ogawara K, Shiiba M, Yokoe H, Tanzawa H: Hyaluronan-mediated motility: a target in oral squamous cell carcinoma. Int J Oncol. 2008, 32: 1001-9.
CAS
PubMed
Google Scholar
Hamilton SR, Fard SF, Paiwand FF, Tolg C, Veiseh M, Wang C, McCarthy JB, Bissell MJ, Koropatnick J, Turley EA: The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. J Biol Chem. 2007, 282: 16667-80. 10.1074/jbc.M702078200.
Article
CAS
PubMed
PubMed Central
Google Scholar
Knüpfer MM, Poppenborg H, Hotfilder M, Kühnel K, Wolff JE, Domula M: CD44 expression and hyaluronic acid binding of malignant glioma cells. Clin Exp Metastasis. 1999, 17: 71-6.
Article
PubMed
Google Scholar
Assmann V, Gillett CE, Poulsom R, Ryder K, Hart IR, Hanby AM: The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behavior of tumour cells. J Pathol. 2001, 195: 191-6. 10.1002/path.941.
Article
CAS
PubMed
Google Scholar
Wang C, Thor AD, Moore DH, Zhao Y, Kerschmann R, Stern R, Watson PH, Turley EA: The overexpression of RHAMM, a hyaluronan -binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res. 1998, 4: 567-76.
CAS
PubMed
Google Scholar
Kong QY, Liu J, Chen XY, Wang XW, Sun Y, Li H: Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder. Oncol Rep. 2003, 10: 51-5.
CAS
PubMed
Google Scholar
Rein DT, Roehrig K, Schöndorf T, Lazar A, Fleisch M, Niederacher D, Bender HG, Dall PJ: Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis. Cancer Res Clin Oncol. 2003, 129: 161-4.
CAS
Google Scholar
Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma. Gastric Cancer. 1998, 1: 10-24. 2
Article
PubMed
Google Scholar
Zlobec I, Baker K, Terracciano L, Peter S, Degen L, Beglinger C, Lugli A: Two-marker protein profile predicts poor prognosis in patients with early rectal cancer. Br J Cancer. 2008, 99: 1712-7. 10.1038/sj.bjc.6604729.
Article
CAS
PubMed
PubMed Central
Google Scholar
Abetamann V, Kern HF, Elsässer HP: Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells. Clin Cancer Res. 1996, 2: 1607-18.
CAS
PubMed
Google Scholar
Li H, Guo L, Li JW, Liu N, Qi R, Liu J: Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression. Int J Oncol. 2000, 17: 927-32.
CAS
PubMed
Google Scholar
Sohr S, Engeland K: Cell Cycle. 2008, 7: 3448-60. 10.4161/cc.7.21.7014.
Article
CAS
PubMed
Google Scholar
Lugli A, Zlobec I, Günthert U, Minoo P, Baker K, Tornillo L, Terracciano L, Jass JR: Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer. Mod Pathol. 2006, 1302-9. 10.1038/modpathol.3800648. 10
Zlobec I, Baker K, Terracciano LM, Lugli A: RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis. Clin Cancer Res. 2008, 14: 3798-806. 10.1158/1078-0432.CCR-07-5103.
Article
CAS
PubMed
Google Scholar
Zlobec I, Baker K, Terracciano L, Peter S, Degen L, Beglinger C, Lugli A: Two-marker protein profile predicts poor prognosis in patients with early rectal cancer. Br J Cancer. 2008, 99: 1712-7. 10.1038/sj.bjc.6604729.
Article
CAS
PubMed
PubMed Central
Google Scholar
Assmann V, Gillett CE, Poulsom R, Ryder K, Hart IR, Hanby AM: The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behavior of tumour cells. J Pathol. 2001, 195: 191-6. 10.1002/path.941.
Article
CAS
PubMed
Google Scholar
Filling the mosaic of p53 actions: p53 represses RHAMM expression Cell Cycle. 2008, 7: 3479-
Lin SL, Chang D, Chiang A, Ying SY: Androgen receptor regulates CD168 expression and signaling in prostate cancer. Carcinogenesis. 2008, 29: 282-90. 10.1093/carcin/bgm259.
Article
CAS
PubMed
Google Scholar